Pre-eclampsia

O15_PREECLAMPS

preeclampsia: Preeclampsia is a hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O14 Hospital discharge: ICD-9 — 642[4-5] Hospital discharge: ICD-8 — 6370[349] Cause of death: ICD-10 — O14 Cause of death: ICD-9 — 642[4-5] Cause of death: ICD-8 — 6370[349] 2 out of 7 registries used, show all original rules.	9313
4. Check minimum number of events None	9313
5. Include endpoints None	9313
6. Filter based on genotype QC (FinnGen only)	9313

Control definitions (FinnGen only)

Control exclude: O15_OEDEM_PROTUR_HYPERT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5
Parent code in ICD-10: O10-O16
Name in latin: Hypertensio gestationalis cum proteinuria significanti

NAME	O15_PREECLAMPS
CONTROL_EXCLUDE	O15_OEDEM_PROTUR_HYPERT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O14
HD_ICD_9	642[4-5]
HD_ICD_8	6370[349]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O14
COD_ICD_9	642[4-5]
COD_ICD_8	6370[349]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-eclampsia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64134	64134	-
Only index persons	62521	62521	-
Unadjusted period prevalence (%)
Whole population	1.84	1.84	-
Only index persons	2.30	2.30	-
Median age at first event (years)
Whole population	-	28.58	-
Only index persons	-	28.55	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9313	9313	-
Unadjusted period prevalence (%)	3.17	3.17	-
Median age at first event (years)	28.74	28.74	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8471: Matched controls
84709

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C07AG01

ATC

labetalol; systemic

51.9

323.0

595

123

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

311

O14.1

ICD-10 Finland

Severe pre-eclampsia

11342.4

323.0

1012

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

2901.9

323.0

564

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

4140.9

323.0

1726

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.5

323.0

2167

7565

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

1258

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

323.0

351

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

323.0

1975

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

+∞

323.0

2468

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2578.8

323.0

2104

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

323.0

426

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

+∞

320.9

306

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

+∞

317.7

303

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

4.0

284.4

1273

3575

205

Kela drug reimbursment

Chronic hypertension

3.1

252.7

1658

6234

I10

ICD-10 Finland

Essential (primary) hypertension

2.2

235.0

3650

21806

O12.1

ICD-10 Finland

Gestational proteinuria

468.3

230.1

229

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

226.0

216

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

2.8

185.8

1403

5660

8811

FHL

Cesarean section

3.2

183.6

1063

3591

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.7

182.8

1415

5792

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.2

174.8

2221

11746

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

3.1

174.6

1087

3858

C09AA02

ATC

enalapril; systemic

2.8

162.7

1226

4907

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.5

158.8

1428

6319

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

157.5

1646

7874

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

155.0

1620

7745

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.3

148.8

416

686

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.5

138.2

701

2121

ZXD05

NOMESCO Finland

Urgent procedure

1.9

137.4

2881

18246

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

4.1

131.2

544

1383

C08CA05

ATC

nifedipine; systemic

3.9

130.3

584

1592

A10BA02

ATC

metformin; oral

2.1

124.8

1658

8749

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.9

121.5

2142

12626

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

+∞

121.1

116

O60

ICD-10 Finland

Preterm labour and delivery

4.0

120.3

517

1356

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.0

119.9

1816

10090

C08CA01

ATC

amlodipine; oral

2.0

116.1

1912

10955

O16

ICD-10 Finland

Unspecified maternal hypertension

114.4

114.3

124

W84

ICPC

Pregnancy high risk

3.4

113.7

609

1913

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

113.1

977

4171

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

4.2

105.2

428

1066

A10AE04

ATC

insulin glargine; parenteral

3.0

102.6

659

2349

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.7

101.8

2940

20130

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

+∞

99.1

SPAT1262

SPAT

Handing over of treatment supplies

2.1

97.3

1209

6130

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.0

94.3

579

1998

T90

ICPC

Diabetes non-insulin dependent

2.0

92.6

1294

6877

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.7

92.5

670

2571

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

89.5

1168

6028

O12.0

ICD-10 Finland

Gestational oedema

55.9

88.3

105

SPAT1379

SPAT

Health check-up of pregnant person

1.9

88.3

1447

8164

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

+∞

87.6

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.7

85.7

393

1087

C07AB02

ATC

metoprolol; systemic

2.0

83.8

1180

6269

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

+∞

80.3

A10AE05

ATC

insulin detemir; parenteral

3.2

77.9

447

1469

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.8

77.5

346

934

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.1

76.4

441

1454

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.5

73.9

363

1061

63709

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD

+∞

73.0

C07AB07

ATC

bisoprolol; oral

1.6

72.6

2622

18636

XMA22

NOMESCO Finland

General examination of pregnant woman

2.2

71.8

815

3934

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.8

70.9

497

1863

C09BA02

ATC

enalapril and diuretics; systemic

3.0

69.9

427

1465

C09CA01

ATC

losartan; oral

1.8

69.8

1372

8180

O30.0

ICD-10 Finland

Twin pregnancy

3.8

67.8

305

829

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.8

67.6

1258

7355

A10AA01

ATC

3.7

67.0

306

842

T89

ICPC

Diabetes insulin dependent

3.2

67.0

375

1210

A10AA02

ATC

3.6

66.4

312

880

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.4

65.8

250

582

W78

ICPC

Pregnancy

1.7

65.5

1747

11402

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

5.4

65.5

203

380

MAC96

NOMESCO Finland

Other induction or advancement of labour

3.0

65.1

404

1399

E66.8

ICD-10 Finland

Other obesity

2.4

64.4

598

2616

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.9

62.4

1104

6328

MAA00

NOMESCO Finland

Amniocentesis

3.0

62.4

378

1288

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.2

61.7

648

3010

SPAT1197

SPAT

Extensive health check-up of expecting family

1.7

61.3

1557

9997

H04AA01

ATC

glucagon; nasal, parenteral

3.7

60.8

278

766

B01AB05

ATC

enoxaparin; parenteral

1.6

60.2

2106

14705

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.0

59.7

862

4586

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

59.6

1460

9267

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.9

58.5

250

650

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

+∞

58.4

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

3.2

57.5

321

1033

C09DA01

ATC

losartan and diuretics; oral

2.2

57.4

606

2818

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

56.7

371

1330

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

+∞

56.3

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

+∞

56.3

C03CA01

ATC

furosemide; systemic

1.8

54.0

1131

6829

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.7

53.5

1244

7751

SPAT1263

SPAT

Sampling

1.4

53.3

3357

26477

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

53.2

341

1206

66180

ICD-8 Finland

Occipital presentation

3.4

53.2

270

810

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

52.9

961

5537

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.5

52.5

262

776

40199

ICD-8 Finland

Essential benign hypertension

8.0

50.5

117

148

C09CA06

ATC

candesartan; oral

1.6

50.4

1525

10195

WX320

NOMESCO Finland

Spinalanesthesy

1.6

50.1

1646

11233

SPAT1380

SPAT

Postpartum check-up

1.7

49.5

1121

6913

A10BK03

ATC

empagliflozin; oral

2.4

49.1

426

1798

C08CA13

ATC

lercanidipine; oral

2.0

49.0

665

3440

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.9

48.1

209

552

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.3

46.2

464

2105

C09AA05

ATC

ramipril; oral

1.7

45.0

1010

6202

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

45.0

348

1378

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.5

44.1

376

1572

O61.0

ICD-10 Finland

Failed medical induction of labour

4.1

43.8

179

448

W81

ICPC

Toxaemia of pregnancy

96.6

43.8

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

3.1

42.5

250

834

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.7

42.5

1086

6914

66120

ICD-8 Finland

Occipital presentation

18.0

42.2

C03AA03

ATC

hydrochlorothiazide; oral

2.1

42.1

497

2425

C02CB01

ATC

40.3

41.5

C02EA02

ATC

4.2

41.5

163

394

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

3.0

41.1

254

877

A10AE06

ATC

insulin degludec; parenteral

3.0

41.0

248

844

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

40.0

3160

25544

W92

ICPC

Compl labour/ delivery livebirth

2.7

39.7

284

1077

A10BH01

ATC

sitagliptin; oral

2.2

39.6

446

2132

C02AC05

ATC

moxonidine; oral

3.2

39.2

214

680

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.8

39.1

774

4564

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

1.9

39.0

597

3227

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.2

38.8

107

175

W85

ICPC

Gestational diabetes

2.1

38.7

470

2320

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

38.6

371

1648

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

38.2

1093

7155

C08CA02

ATC

felodipine; oral

2.2

37.9

392

1801

J01DA01

ATC

[U] cefalexin; systemic

1.3

37.9

5090

44657

A10BJ06

ATC

semaglutide; parenteral

2.9

37.7

241

852

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.4

37.6

116

218

SPAT1196

SPAT

Monitoring of normal pregnancy

1.7

36.6

834

5129

C09DA06

ATC

candesartan and diuretics; oral

2.1

36.5

423

2045

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

35.7

172

497

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.7

35.7

259

990

J01DB01

ATC

cefalexin; oral

1.4

35.4

6655

61265

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

35.4

714

4229

H3603, E103

ICD-10 Finland

4.7

34.8

121

260

C10AA01

ATC

simvastatin; oral

1.4

34.6

1718

12702

H3600, E103

ICD-10 Finland

4.2

34.4

135

327

O99.80

ICD-10 Finland

The fear of childbirth

1.8

33.4

581

3280

K85

ICPC

Elevated blood pressure

1.7

33.4

769

4739

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

+∞

33.3

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.7

33.2

116

251

O14

ICD-10 Finland

Pre-eclampsia

328.4

32.9

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.9

32.6

139

364

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

3.0

31.7

192

657

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.8

31.0

579

3342

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

30.8

852

5512

H3601, E103

ICD-10 Finland

4.8

30.6

104

219

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.1

30.5

121

297

G47.3

ICD-10 Finland

Sleep apnoea

1.5

30.4

1148

7994

C07AG02

ATC

carvedilol; oral

2.5

30.2

246

1004

6423B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]

+∞

30.2

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

30.2

953

6370

160

Kela drug reimbursment

exenatide

3.5

30.1

147

431

K86

ICPC

Hypertension uncomplicated

1.8

29.8

525

2976

N02BE01

ATC

paracetamol; systemic, rectal

1.4

29.5

6855

63928

C10AA05

ATC

atorvastatin; oral

1.4

29.4

1622

12181

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.2

28.9

113

274

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.8

28.6

188

678

A10BB12

ATC

glimepiride; oral

2.5

28.5

228

921

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

28.3

908

6086

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

28.2

991

6785

SPAT1310

SPAT

Counselling related to known health issue

1.3

28.2

2284

18272

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.0

28.2

169

575

Z30.2

ICD-10 Finland

Sterilization

1.5

28.1

1087

7601

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

5.1

28.0

179

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.6

27.9

872

5807

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.5

27.5

216

867

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

27.3

331

1632

A10BK01

ATC

dapagliflozin; oral

2.4

27.2

242

1035

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

27.2

477

2699

A10BJ02

ATC

liraglutide; parenteral

3.0

27.2

163

555

A12BA01

ATC

potassium chloride; oral

3.1

26.9

155

514

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.5

26.8

1177

8442

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.6

26.4

199

781

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

26.2

506

2952

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

5.7

26.1

135

T82

ICPC

Obesity

2.0

26.0

339

1724

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

25.9

1174

8468

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.0

25.5

354

1841

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.4

25.2

221

940

SPAT1301

SPAT

No procedures

1.3

25.1

2090

16728

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.6

24.6

111

307

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

24.6

219

939

ZXD00

NOMESCO Finland

Emergency procedure

2.2

24.5

264

1240

6563B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]

2.4

24.2

216

928

6461A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Oedema or excessive weight gain in pregnancy, without mention of hypertension

+∞

24.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

23.7

366

1983

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

2.5

23.6

191

779

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

7.6

23.5

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.7

23.4

162

606

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.2

23.0

124

394

WX290

NOMESCO Finland

Other blockade of nerve

1.3

22.9

3735

32596

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.6

22.7

177

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.6

22.6

103

288

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.7

22.5

269

WX892

NOMESCO Finland

Monitored bed care

1.8

22.4

367

2030

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.6

22.4

116

O84.2

ICD-10 Finland

Multiple delivery, all by caesarean section

4.4

22.3

185

K02.1

ICD-10 Finland

Caries of dentine

1.3

21.9

4604

41303

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

21.9

2839

24047

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.8

21.6

137

486

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.6

21.5

164

C07FB02

ATC

metoprolol and felodipine; systemic

3.2

21.4

114

360

C10AA07

ATC

rosuvastatin; oral

1.4

21.4

1142

8477

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

21.3

2316

19158

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

4.9

21.3

144

C09CA03

ATC

valsartan; oral

1.8

21.0

375

2136

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

20.7

4197

37393

R51.80

ICD-10 Finland

Headache

1.4

20.5

1192

8975

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

20.5

3327

28888

C03BA11

ATC

indapamide; oral

2.8

20.5

134

485

Z39.1

ICD-10 Finland

Care and examination of lactating mother

2.1

20.3

231

1110

SPAT1153

SPAT

Removal of sutures

1.3

20.2

1910

15487

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.8

20.2

228

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

20.1

655

4393

WX110

NOMESCO Finland

Local anesthesy

1.2

20.0

5511

50717

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.4

20.0

174

738

A10BX07

ATC

[U] liraglutide; parenteral

3.6

19.9

246

O41.0

ICD-10 Finland

Oligohydramnios

2.2

19.9

211

986

J01CA08

ATC

pivmecillinam; oral

1.2

19.8

4055

36084

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.9

19.8

302

1628

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

1.8

19.6

318

1751

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

2.4

19.6

166

697

W29

ICPC

Pregnancy symptom/complaint other

1.9

19.5

276

1449

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

2.8

19.5

129

470

O02.1

ICD-10 Finland

Missed abortion

1.6

19.4

582

3827

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

19.3

611

4071

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

19.3

2332

19507

A08AB01

ATC

orlistat; oral

4.4

19.2

161

65700

ICD-8 Finland

Occipital presentation

2.9

19.2

114

390

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.1

19.1

107

352

Z3232

NOMESCO Finland

Midwife

1.4

19.0

960

7042

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

18.9

1948

15958

63799

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified

+∞

18.8

C09AA03

ATC

lisinopril; oral

2.2

18.7

192

884

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

18.6

1834

14933

C01DA14

ATC

isosorbide mononitrate; oral

1.8

18.4

298

1642

C07BB07

ATC

bisoprolol and thiazides; systemic

2.1

18.4

205

978

E66

ICD-10 Finland

Obesity

1.8

18.3

345

1997

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

2.0

18.2

232

1172

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

18.1

2077

17234

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

5.4

18.0

101

C07AB03

ATC

atenolol; systemic

2.0

18.0

225

1127

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

17.9

4675

42497

C09DA03

ATC

valsartan and diuretics; oral

2.1

17.9

215

1060

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

17.8

693

4829

O15.0

ICD-10 Finland

Eclampsia in pregnancy

+∞

17.7

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

17.7

1412

11153

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

17.6

242

1259

H36.01

ICD-10 Finland

Diabetic maculopathy

3.8

17.5

191

A10AA03

ATC

3.8

17.5

191

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.3

17.4

1515

12109

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

17.4

535

3539

SPAT1097

SPAT

Recording of ECG

1.5

17.3

723

5114

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.7

17.3

115

422

O46.0

ICD-10 Finland

Antepartum haemorrhage with coagulation defect

20.9

17.3

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

17.2

449

2853

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

17.1

801

5790

6542B

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, SYNNYTYKSEN AIKANA]

2.7

17.0

114

420

M04AA01

ATC

allopurinol; systemic

1.8

16.7

313

1808

ZXE00

NOMESCO Finland

One hour or less

1.2

16.7

2928

25457

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

16.7

817

5953

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

16.6

973

7316

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

1.7

16.6

381

2339

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

6.9

16.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

16.2

295

N02AX02

ATC

tramadol; systemic, rectal

1.2

16.2

2588

22260

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

2.6

16.1

116

445

J01CA04

ATC

amoxicillin; systemic

1.3

16.1

6660

63151

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

16.1

1857

15386

J01AA02

ATC

doxycycline; systemic

1.2

16.0

6088

57157

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

16.0

2906

25331

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

16.0

365

2237

162

Kela drug reimbursment

liraglutide

3.5

15.8

214

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

3.2

15.8

262

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

15.8

1038

7948

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

2.6

15.7

114

442

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

15.7

905

6790

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

15.4

790

5799

B01AC04

ATC

clopidogrel; oral

1.6

15.4

388

2445

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.6

15.3

417

2682

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

15.3

4310

39187

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

15.2

296

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

15.1

177

867

8221

FHL

Sterilization of the laparotomy pathway

1.8

15.1

262

1482

R80

ICD-10 Finland

Isolated proteinuria

4.4

15.0

124

M79.6

ICD-10 Finland

Pain in limb

1.2

15.0

2528

21824

M54.5

ICD-10 Finland

Low back pain

1.2

15.0

2430

20896

A10BX04

ATC

[U] exenatide; parenteral

3.4

14.9

219

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

14.9

5802

54344

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

14.9

1391

11207

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.8

2905

25468

SPAT1254

SPAT

Administration of medicine

1.4

14.8

721

5247

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

14.8

608

4282

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.6

14.8

105

403

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.4

14.8

121

500

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.1

14.7

171

836

A10BD07

ATC

metformin and sitagliptin; systemic

2.1

14.6

171

837

C07AB08

ATC

celiprolol; oral

2.8

14.6

323

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

14.6

2574

22317

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

14.6

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.9

14.6

152

C10AX09

ATC

ezetimibe; oral

1.6

14.5

399

2574

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.8

14.5

253

1436

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

14.5

386

2469

J01FF01

ATC

clindamycin; systemic

1.3

14.4

1789

14917

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.7

14.4

312

1888

6542A

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, RASKAUDEN AIKANA]

3.6

14.4

179

SPAT1312

SPAT

General health counselling

1.2

14.3

2261

19366

ACC51

NOMESCO Finland

Release of median nerve

1.5

14.2

510

3493

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

14.2

2580

22425

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.0

14.1

278

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

14.1

1198

9524

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.8

13.9

149

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

13.8

105

419

A10BG03

ATC

pioglitazone; oral

2.5

13.6

104

415

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

13.6

157

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.6

13.5

382

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

13.5

3009

26635

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

1.9

13.5

186

971

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

13.5

420

2786

C07AB05

ATC

betaxolol; oral

2.6

13.4

377

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

13.4

1998

16985

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.9

13.4

139

C09DA07

ATC

telmisartan and diuretics; oral

1.9

13.2

182

951

A10AB06

ATC

insulin glulisine; parenteral

3.3

13.2

197

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.7

13.2

280

1686

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

13.0

459

3130

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.8

13.0

289

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

13.0

335

A02BC01

ATC

omeprazole; systemic

1.2

13.0

1688

14132

C03DA01

ATC

spironolactone; oral

1.5

12.9

385

2530

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.2

12.9

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

2.5

12.9

385

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

12.9

1107

8802

O32.1

ICD-10 Finland

Maternal care for breech presentation

1.5

12.9

423

2842

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

12.8

5511

51650

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.2

12.7

133

622

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.7

12.7

327

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

12.5

341

2199

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

2.2

12.4

120

541

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

5.0

12.4

B05DB

ATC

Hypertonic solutions

5.2

12.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.3

3781

34358

AA1AD

NOMESCO Finland

CT of head and brain

1.3

12.3

1051

8351

H03AA01

ATC

levothyroxine sodium; systemic

1.2

12.2

1839

15628

I25.2

ICD-10 Finland

Old myocardial infarction

2.4

12.2

100

418

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.8

12.2

225

1300

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

12.2

3886

35421

K04.0

ICD-10 Finland

Pulpitis

1.4

12.1

733

5537

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.4

12.0

164

O20.0

ICD-10 Finland

Threatened abortion

1.7

12.0

261

1583

66170

ICD-8 Finland

3.9

12.0

124

A10BH05

ATC

linagliptin; oral

2.0

12.0

140

690

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

11.9

112

501

O67.0

ICD-10 Finland

Intrapartum haemorrhage with coagulation defect

46.7

11.9

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.1

11.9

198

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

11.8

607

4455

H3600, E113

ICD-10 Finland

4.0

11.8

116

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.4

11.8

688

5162

MAW96

NOMESCO Finland

Other operation in pregnancy or at delivery

2.7

11.8

289

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

11.7

118

543

137

Kela drug reimbursment

Uraemia requiring dialysis

4.0

11.7

112

6563A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, RASKAUDEN AIKANA]

4.9

11.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

11.6

1125

9086

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

4.5

11.6

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.4

11.5

380

O41.1

ICD-10 Finland

Infection of amniotic sac and membranes

2.4

11.5

392

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.2

11.5

112

511

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

11.4

1947

16737

B05DA

ATC

Isotonic solutions

4.5

11.4

MBA04

NOMESCO Finland

Curettage of uterus after delivery

2.9

11.4

238

AN1

Coronary angiography

1.6

11.3

266

1653

Z39.0

ICD-10 Finland

Care and examination immediately after delivery

2.2

11.3

112

512

C08CA10

ATC

nilvadipine; oral

2.6

11.2

297

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

11.1

292

1866

A10BJ01

ATC

exenatide; parenteral

3.1

11.1

191

Y4300

ICD-8 Finland

Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)

2.2

11.1

109

500

A46

ICD-10 Finland

Erysipelas

1.4

11.0

524

3796

O40

ICD-10 Finland

Polyhydramnios

2.1

10.9

115

542

A10BD03

ATC

metformin and rosiglitazone; systemic

3.3

10.9

161

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

10.9

136

688

N97.0

ICD-10 Finland

Female infertility associated with anovulation

1.7

10.9

206

1202

P01AB01

ATC

metronidazole; oral, rectal

1.2

10.9

3220

29064

Z36.8

ICD-10 Finland

Other antenatal screening

1.7

10.9

202

1172

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.5

10.9

420

2924

M65.3

ICD-10 Finland

Trigger finger

1.6

10.8

268

1688

O72.1

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3009508) Creatinine [Moles/volume] in Urine

3380

18010

2.38

321.37

4.1

3.0

mmol/l

11.3

7.1

0.49

2965

15340

(3012516) Albumin [Mass/volume] in Urine

3201

15372

2.65

307.65

4.1

3.1

mg/l

396.0

536.6

1.03

2241

8702

(3020682) Albumin/Creatinine [Ratio] in Urine

3328

16138

2.65

307.65

5.2

3.8

mg/mmol

27.0

7.0

40.11

2348

9375

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1322

5766

2.51

184.16

4.3

4.0

u/l

244.5

235.2

0.73

1263

5446

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

621

1987

3.28

153.49

3.2

1.7

g/l

1.1

1.5

17.94

560

1704

(3026493) Urate [Moles/volume] in Serum or Plasma

2694

17022

1.82

135.50

3.1

2.0

umol/l

2465.5

2982.3

0.39

2429

14982

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

506

2150

2.43

72.16

2.5

2.4

g/l

4.0

3.6

8.81

471

2032

(3013826) Glucose [Moles/volume] in Serum or Plasma

4912

40291

1.46

68.28

4.6

3.9

mmol/l

6.8

6.3

25.72

4473

36762

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

297

1021

2.97

64.37

2.8

2.4

ug/min

159.0

44.2

2.47

191

617

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

701

3566

2.04

64.11

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

8476

78629

1.87

63.80

13.6

10.9

mmol/l

139.5

139.7

14.19

8299

76592

(3023103) Potassium [Moles/volume] in Serum or Plasma

8492

78863

1.87

63.13

13.8

11.0

mmol/l

3.9

16.27

8299

76635

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

767

4056

1.97

62.85

1.6

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

591

2928

2.09

57.92

1.5

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

151

377

4.05

53.84

2.9

1.6

g/24h

1.7

1.0

0.68

(3032080) INR in Blood by Coagulation assay

3004

23211

1.43

53.12

6.1

5.5

inr

1.1

1.29

1084

7308

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1295

8544

1.60

48.55

1.6

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2390

17973

1.44

47.93

2.3

1.7

mg/l

1.4

0.9

7.07

1863

13412

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3743

30508

1.38

46.82

4.1

3.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7467

68403

1.46

44.51

6.3

4.5

mmol/mol

40.5

37.8

92.97

7082

64234

(3029937) Albumin [Presence] in Urine by Test strip

2648

20583

1.40

43.20

4.4

3.6

estimate

0.0

0.11

1048

7567

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2906

22985

1.38

42.59

3.0

2.7

ng/l

30.7

58.5

0.49

1582

11358

(3037121) Protein [Mass/volume] in Urine

413

2022

2.09

41.62

3.2

2.8

g/l

0.6

0.3

6.44

212

703

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

336

1536

2.23

40.30

3.8

2.8

mg/l

1.5

1.3

3.42

319

1439

(3037467) Urinalysis macro (dipstick) panel - Urine

6122

54649

1.35

39.09

4.6

4.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2354

18292

1.38

37.41

1.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

2836

22720

1.36

37.15

2.9

2.6

—

(3035350) Ketones [Presence] in Urine by Test strip

4558

39193

1.32

36.48

4.0

3.3

estimate

0.0

1.15

1057

7403

(3009261) Glucose [Presence] in Urine by Test strip

4598

39752

1.31

34.63

4.1

3.3

estimate

0.0

0.17

1030

7564

(3021601) Nitrite [Presence] in Urine by Test strip

4559

39453

1.30

33.71

5.3

4.5

estimate

0.0

0.10

1081

7585

(3041096) Erythrocytes [Presence] in Urine by Automated

2771

22381

1.34

33.62

3.3

2.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8733

83676

1.70

33.12

14.6

11.8

umol/l

68.7

66.7

8.24

8727

83638

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1241

8766

1.48

33.02

2.2

2.0

28.6

29.2

3.95

1188

8481

(3034274) Bile acid [Moles/volume] in Serum --fasting

374

1931

1.98

32.53

2.4

2.1

umol/l

6.3

5.5

0.49

280

1413

(3024561) Albumin [Mass/volume] in Serum or Plasma

3480

29159

1.31

32.19

5.3

4.2

g/l

35.3

36.5

29.74

3258

27152

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1063

7321

1.51

31.96

6.6

4.8

mmol/l

1.1

1.0

3.13

1001

6839

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8799

84595

1.73

31.41

11.1

9.1

u/l

25.8

24.0

11.12

8602

82079

(3019832) Treponema pallidum Ab [Presence] in Serum

1800

13728

1.39

31.17

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4355

37787

1.29

30.18

4.4

3.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5831

52587

1.29

29.43

4.7

4.0

e6/l

838.2

1994.8

1.56

564

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2780

22851

1.31

28.77

2.8

2.4

u/l

53.5

57.1

1.29

2595

21112

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1747

13571

1.35

26.40

2.7

2.5

ng/l

899.4

685.4

1.40

1455

11203

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1502

11410

1.38

26.13

1.9

—

(3013512) EKG study

2239

18075

1.31

25.89

3.5

3.0

—

(3004775) Volume in Urine collected for unspecified duration

101

317

3.21

25.78

2.7

2.3

596.3

624.0

0.31

245

(3016750) Collection duration of Urine

240

3.57

25.62

2.6

2.2

min

509.5

500.2

0.40

202

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1827

14404

1.33

24.81

1.7

1.6

pmol/l

58843093.7

35289791.2

0.50

1538

12338

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4241

37260

1.25

24.40

5.5

5.6

umol/l

9.7

9.6

0.10

3999

35200

(40761536) Microorganisms panel - Urine sediment

966

6897

1.45

23.86

4.1

3.4

—

(3015736) pH of Urine

3488

30058

1.26

23.44

3.8

3.1

—

6.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3085

26314

1.26

22.36

3.1

u/l

35.5

29.9

0.92

2925

25102

(3020779) Urea [Moles/volume] in Serum or Plasma

630

4180

1.54

22.28

9.3

6.7

mmol/l

8.8

7.5

4.73

612

4007

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

411

2457

1.70

22.24

2.1

2.0

90.9

96.1

4.11

379

2241

(3036489) Thrombin time

464

2866

1.65

22.18

2.0

1.9

21.0

20.8

0.59

395

2399

(3009343) pH of Capillary blood

484

3023

1.63

22.13

3.1

2.9

7.4

0.75

403

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7293

68567

1.29

22.04

4.9

4.4

pmol/l

14.5

14.4

3.91

6839

64093

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

487

3066

1.62

21.57

3.2

2.9

kpa

5.2

5.1

1.49

458

2853

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6239

57662

1.25

21.23

7.5

6.9

u/l

77.4

74.1

5.85

5904

54392

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

463

2912

1.62

20.59

3.1

2.8

mmol/l

1.7

1.6

0.17

342

2134

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7782

73980

1.32

20.42

11.1

9.6

ml/min/173m2

87.9

88.2

0.62

6613

60368

(3022217) INR in Platelet poor plasma by Coagulation assay

867

6270

1.42

19.82

15.4

14.4

inr

1.2

1.1

0.64

148

1019

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

384

2344

1.67

19.23

2.3

2.2

184.8

171.2

2.33

363

2207

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8101

77590

1.34

19.13

4.4

3.8

mmol/l

1.5

1.6

94.17

7665

73159

(4146454)

123

511

2.43

18.60

2.8

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1299

10144

1.33

18.29

3.2

mmol/l

0.9

0.8

6.30

1232

9470

(3023368) Bacteria identified in Blood by Culture

1800

14703

1.28

18.04

3.9

3.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8064

77299

1.32

18.02

5.7

5.1

mu/l

1.7

2.0

3.86

7627

72846

(3008152) Bicarbonate [Moles/volume] in Arterial blood

461

2990

1.57

18.02

5.5

6.6

mmol/l

24.5

24.6

0.31

419

2765

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7820

74666

1.30

17.87

4.0

3.4

mmol/l

1.3

1.2

42.55

7381

70105

(3007853) Bacteria identified in Skin by Aerobe culture

1102

8428

1.35

17.85

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8203

78868

1.34

17.60

4.8

4.1

mmol/l

2.9

9.58

7721

74078

(3019150) Specific gravity of Urine by Refractometry

1998

16572

1.26

17.58

4.5

3.6

kg/l

1.0

1.88

328

2511

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8125

78014

1.33

17.57

4.5

3.8

mmol/l

4.8

4.9

27.29

7688

73723

(3044640) Blood type and Crossmatch panel - Blood

2831

24414

1.23

17.48

2.2

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

212

1123

1.91

17.24

1.1

iu/ml

72.4

9776.0

0.64

275

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

767

2.11

17.23

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

789

5755

1.41

17.11

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

766

5582

1.41

16.70

3.0

2.3

ml/min/173m2

69.0

74.3

2.64

275

2085

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

842

6260

1.38

16.28

2.8

2.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

219

1197

1.85

16.19

4.1

2.3

nmol/l

0.9

0.8

0.89

176

1013

(3016502) Oxygen saturation in Arterial blood

672

4824

1.42

15.94

5.9

7.3

96.3

96.2

0.13

638

4627

(3044889) 12 lead EKG panel

5453

50348

1.20

15.93

3.2

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

347

2172

1.62

15.78

3.9

2.9

mmol/l

25.2

25.5

0.82

338

2098

(3015235) Bicarbonate [Moles/volume] in Capillary blood

212

1162

1.84

15.55

2.9

2.6

mmol/l

24.3

24.7

0.62

191

1022

(3012544) pH of Venous blood

630

4492

1.43

15.52

4.9

3.5

7.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7838

75131

1.27

15.50

4.5

3.8

mmol/l

6.0

5.6

61.19

7346

70116

(3021447) Carbon dioxide [Partial pressure] in Venous blood

612

4342

1.44

15.49

5.0

3.6

kpa

5.9

5.8

0.29

597

4206

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2261

19261

1.23

15.29

2.0

u/l

138.0

143.8

0.24

2127

18145

(3019060) Gas panel - Arterial blood

454

3045

1.52

15.27

3.8

4.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

532

3694

1.47

15.08

2.1

ug/l

4.5

5.9

1.68

468

3191

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

853

6459

1.35

14.65

2.7

2.1

u/l

8231.8

5524.3

1.50

389

2581

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2095

17796

1.23

14.43

2.4

2.1

mg/l

3.0

2.7

5.54

1841

15311

(3013707) Erythrocyte sedimentation rate by Westergren method

6314

59335

1.20

14.29

4.4

3.9

mm/h

12.2

10.5

19.43

5944

55706

(3002032) Base excess in Venous blood by calculation

602

4326

1.42

14.19

5.4

3.6

mmol/l

1.7

2.0

0.98

497

3550

(3002173) Hemoglobin [Mass/volume] in Arterial blood

634

4598

1.41

14.19

6.3

7.6

g/l

119.3

120.2

0.57

597

4418

(3000850) Epithelial cells [#/volume] in Urine

1661

13792

1.25

14.09

2.8

2.3

e6/l

8.1

8.2

0.07

1451

11955

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3744

33665

1.19

13.99

6.9

5.6

mmol/l

1.2

3.87

3147

28515

(3036481) Cortisol [Moles/volume] in Serum or Plasma

988

7721

1.31

13.63

2.0

2.1

nmol/l

352.9

376.8

3.56

900

7116

(3016244) Insulin [Units/volume] in Serum or Plasma

130

634

2.07

13.48

4.0

3.5

mu/l

28.5

28.9

0.04

123

608

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1071

8494

1.29

13.22

3.0

2.3

22.7

23.4

0.96

922

7342

(40761511) CBC panel - Blood by Automated count

8705

84919

1.38

13.15

13.3

10.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

588

4267

1.40

13.11

2.7

2.4

g/l

66.4

67.2

1.52

545

3929

(3024354) Oxygen [Partial pressure] in Venous blood

494

3484

1.44

12.92

4.0

3.0

kpa

4.6

4.7

0.00

483

3365

(3022313) Gas panel - Capillary blood

331

2155

1.56

12.80

3.2

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2467

21513

1.20

12.71

2.0

1.9

—

(40768446) Kidney Pathology biopsy report

196

2.92

12.65

1.8

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

740

5607

1.35

12.62

6.1

6.8

kpa

13.0

13.4

1.39

706

5366

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

260

1607

1.64

12.52

1.5

1.3

u/ml

17.6

20.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

739

5610

1.34

12.45

6.1

6.8

kpa

5.0

5.1

1.96

707

5373

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1167

9425

1.27

12.44

2.9

2.2

g/l

2.4

2.5

0.26

1080

8742

(3004119) Hemoglobin [Mass/volume] in Venous blood

412

2828

1.48

12.42

4.1

3.1

g/l

126.4

129.6

2.31

401

2755

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.32

12.37

4.8

5.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3359

30174

1.18

12.16

6.1

4.9

mmol/l

1.2

2.42

3083

27492

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

243

1493

1.64

12.00

1.5

1.3

u/ml

127.3

110.9

0.60

352

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

10.85

11.95

4.2

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

182

1039

1.77

11.78

1.3

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

238

2.66

11.76

42.2

32.7

ug/l

7.3

7.4

0.05

218

(3042733) HLA Ab [Presence] in Serum

162

3.04

11.68

4.9

—

(3003396) Base excess in Arterial blood by calculation

734

5620

1.33

11.66

6.1

6.8

mmol/l

0.8

1.0

0.64

567

4382

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

105

500

2.11

11.66

1.4

nmol/l

1.6

1.5

0.89

453

(3023520) Reticulocytes [#/volume] in Blood

542

3962

1.39

11.59

2.8

2.5

e9/l

75.4

71.5

1.43

413

2865

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

206

1224

1.70

11.57

1.6

mmol/l

7.9

7.5

1.49

133

752

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

648

4884

1.35

11.45

4.4

3.2

ng/l

90.4

75.7

3.07

556

4276

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

498

2.10

11.39

1.2

1.1

u/ml

38.6

10.3

0.50

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

257

1623

1.60

11.38

1.6

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1268

10445

1.25

11.35

2.9

2.2

umol/l

13.4

14.1

3.41

1175

9696

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

268

1715

1.58

11.22

1.9

2.0

ug/l

1.8

0.05

242

1534

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

316

2103

1.52

11.11

4.1

2.8

0.7

0.91

303

2011

(3020891) Body temperature

292

1911

1.55

11.09

5.0

4.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

512

3742

1.39

10.97

2.5

ng/l

134.2

121.3

0.32

452

3396

(3017181) Myelocytes/100 leukocytes in Blood

777

6049

1.31

10.97

4.3

4.0

0.9

0.01

203

1406

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

321

2150

1.51

10.95

4.1

2.9

1.2

1.3

1.83

321

2132

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2246

19644

1.19

10.90

1.7

1.6

mmol/l

1.4

1.3

5.41

1876

16918

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4499

41583

1.16

10.85

3.3

2.9

ug/l

81.4

76.8

0.84

4257

39329

(1616796) Gas panel - Central venous blood

194

1158

1.69

10.75

3.4

2.7

—

(3026782) Osmolality of Urine

1488

12552

1.22

10.60

2.9

2.5

mosm/kgh2o

529.8

513.9

1.77

1313

10630

(3014576) Chloride [Moles/volume] in Serum or Plasma

815

6418

1.30

10.56

6.5

mmol/l

104.4

104.7

1.15

797

6299

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

257

1656

1.57

10.48

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

745

5810

1.31

10.38

4.4

4.1

0.1

0.2

0.13

189

1310

(3027945) Reticulocytes/100 erythrocytes in Blood

722

5611

1.31

10.32

2.6

2.4

1.9

1.8

2.37

640

4983

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

298

1992

1.51

10.29

3.9

4.7

1.5

1.7

3.11

276

1854

(3025159) Blasts/100 leukocytes in Blood

714

5546

1.31

10.25

4.3

4.1

0.1

0.4

1.06

159

1118

(3002179) Metamyelocytes/100 leukocytes in Blood

717

5574

1.31

10.23

3.9

0.7

0.6

0.07

145

1040

(3000991) Gas panel - Venous blood

550

4121

1.36

10.11

8.7

7.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

403

2869

1.42

10.07

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

242

1556

1.57

9.98

1.3

1.2

u/ml

274.9

272.3

0.05

179

1032

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8265

80430

1.25

9.86

13.1

10.9

mg/l

18.1

19.0

1.97

6817

61604

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2077

18186

1.18

9.80

2.2

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

192

1175

1.65

9.72

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

319

2.27

9.63

1.9

1.8

nmol/l

1.5

1.3

0.58

260

(3012565) Volume of 24 hour Urine

314

2.27

9.54

2.5

1.9

1772.7

1967.2

0.99

292

(3007930) Methemoglobin/Hemoglobin.total in Blood

291

1971

1.49

9.46

3.9

4.8

0.9

0.06

270

1838

(3014111) Lactate [Moles/volume] in Serum or Plasma

579

4418

1.33

9.44

6.7

6.5

mmol/l

1.2

0.08

563

4279

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.22

9.36

7.5

12.4

mmol/l

4.4

4.8

0.42

(4034850)

343

2409

1.44

9.26

9.6

7.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1113

9257

1.23

9.02

1.7

—

(3019225) pH of Specimen

813

6533

1.27

8.96

4.1

3.6

—

(3010421) pH of Blood

222

1437

1.56

8.94

3.2

2.8

7.4

0.56

185

1194

(3019309) Folate [Moles/volume] in Red Blood Cells

1258

10609

1.21

8.89

1.8

1.7

nmol/l

1237.7

1179.6

1.44

1012

8175

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1877

16413

1.18

8.88

1.3

u/ml

9.5

10.9

0.40

823

6880

(3028626) Oxygen [Partial pressure] in Capillary blood

168

1019

1.66

8.84

2.6

2.3

kpa

8.7

8.6

0.49

155

949

(3022493) Free Hemoglobin [Mass/volume] in Plasma

213

2.50

8.83

1.3

4.7

mg/l

91.6

1718.0

0.77

153

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

223

1450

1.55

8.81

3.4

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2387

21290

1.16

8.80

1.7

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

2241

19902

1.17

8.72

3.3

2.8

e6/l

28.5

72.2

3.69

1764

14796

(3021589) Normoblasts [#/volume] in Blood

3757

34622

1.14

8.72

9.5

8.2

e9/l

0.0

0.02

3234

28370

(40767503) Oxygen content in Capillary blood by calculation

177

1094

1.63

8.66

2.4

2.1

16.8

16.6

0.21

524

(3021901) Oxygen saturation in Capillary blood

142

828

1.73

8.66

2.6

2.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

434

2.01

8.65

1.8

2.0

—

(3042936) Bacteria identified in Isolate by Culture

1103

9212

1.22

8.57

2.1

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

167

1021

1.65

8.54

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

149

887

1.69

8.44

1.4

1.5

mmol/l

10.1

10.9

0.42

135

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

282

1946

1.46

8.39

3.3

3.0

mmol/l

25.0

24.9

0.31

264

1814

(3013290) Carbon dioxide [Partial pressure] in Blood

191

1214

1.59

8.35

3.1

2.9

kpa

5.0

0.41

185

1194

(3012501) Base excess in Blood by calculation

191

1214

1.59

8.35

3.1

2.9

mmol/l

2.3

2.4

0.41

113

800

(3003694) ABO and Rh group [Type] in Blood

2771

25065

1.15

8.34

1.8

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

101

538

1.89

8.32

3.3

2.6

mg/l

134.0

23.8

3.77

358

(3027315) Oxygen [Partial pressure] in Blood

193

1231

1.58

8.31

3.1

2.9

kpa

9.0

8.8

0.52

187

1211

(40760892) CBC W Ordered Manual Differential panel - Blood

2169

19275

1.16

8.31

4.6

4.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2426

21753

1.16

8.23

1.3

u/ml

1.3

1.5

0.36

780

6218

(3004588) Protein electrophoresis panel - Serum or Plasma

457

3443

1.34

8.15

2.2

2.1

—

(3047181) Lactate [Moles/volume] in Blood

255

1737

1.48

8.12

3.9

5.1

mmol/l

1.2

0.92

221

1530

(3024471) HLA-A [Type]

183

2.52

7.87

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

217

1443

1.52

7.78

3.7

4.0

mmol/l

3.8

1.58

208

1359

(3011985) Renin [Units/volume] in Plasma

161

1009

1.61

7.51

1.7

mu/l

67.9

51.9

0.33

144

916

(40761535) Cells panel - Urine sediment

652

5224

1.27

7.38

4.4

3.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

938

1.62

7.32

1.5

1.4

pmol/l

457.8

358.8

0.50

126

730

(3021960) Folate [Moles/volume] in Serum or Plasma

1656

14541

1.17

7.30

1.5

1.4

nmol/l

21.2

21.4

0.33

1437

12666

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

374

2789

1.36

7.18

2.2

1.9

g/l

0.2

0.04

357

2647

(3036525) Urea [Moles/time] in 24 hour Urine

7.70

7.11

1.8

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

669

5403

1.26

7.08

3.8

3.2

mmol/l

1.2

0.45

597

4733

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

382

2871

1.34

6.98

2.2

1.9

g/l

1.2

1.54

369

2731

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

356

2647

1.36

6.97

7.2

8.8

—

(3030467) Casts [#/volume] in Urine by Automated count

2037

18241

1.15

6.85

3.2

2.7

e6/l

0.3

0.65

1609

13292

(3024932) HLA-DR beta [Type]

179

2.41

6.74

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

143

896

1.61

6.73

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

833

6942

1.22

6.60

3.4

3.3

pmol/l

4.5

0.19

753

6224

(3009445) Proteinase 3 Ab [Units/volume] in Serum

368

2787

1.33

6.41

1.5

u/ml

5.8

8.0

—

(3037522) Nuclear Ab [Titer] in Serum

1482

13036

1.16

6.33

1.4

titre

529.8

573.7

0.40

317

2782

(3039000) Anion gap in Blood

170

1128

1.52

6.25

4.7

6.4

mmol/l

11.3

11.0

0.51

149

1006

(3018572) Chloride [Moles/volume] in Blood

170

1129

1.52

6.23

4.7

6.4

mmol/l

105.4

0.01

149

1007

(3007461) Platelets [#/volume] in Blood

9107

90195

1.44

6.20

20.3

16.4

e9/l

267.1

268.4

1.19

8981

88354

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

471

1.79

6.00

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

111

2.71

6.00

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

236

1688

1.41

5.91

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

193

1333

1.46

5.85

1.6

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

315

2368

1.34

5.81

1.8

1.9

—

(3035941) MCH [Entitic mass]

9109

90257

1.42

5.78

20.2

16.3

29.9

30.1

18.42

9028

89337

(3000963) Hemoglobin [Mass/volume] in Blood

9113

90305

1.43

5.76

20.4

16.4

g/l

132.7

133.0

1.93

9031

89387

(1761868) Lipid panel - Serum or Plasma

3400

31702

1.11

5.74

2.7

2.4

—

(3026361) Erythrocytes [#/volume] in Blood

9110

90276

1.42

5.70

20.3

16.3

e12/l

4.5

4.4

3.56

8965

88301

(3010813) Leukocytes [#/volume] in Blood

9111

90289

1.42

5.68

20.3

16.4

e9/l

6.9

6.6

46.61

8967

88255

(3024731) MCV [Entitic volume]

9109

90267

1.42

5.67

20.2

16.3

90.0

90.5

27.68

9028

89349

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1903

17163

1.14

5.64

1.3

iu/ml

29.6

32.9

0.31

620

5449

(3034770) Mitochondria Ab [Titer] in Serum

299

2241

1.35

5.64

1.3

titre

848.7

875.2

0.04

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

340

2601

1.32

5.57

1.9

2.0

—

(3014007) Fractional oxyhemoglobin in Arterial blood

389

3034

1.29

5.53

7.5

8.6

94.3

94.2

0.05

389

3022

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

104

635

1.64

5.51

1.1

ratio

1.0

1.1

2.40

228

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

297

2233

1.34

5.49

1.7

1.6

titre

575.3

290.6

0.51

106

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

199

1401

1.43

5.48

3.7

3.1

mg/l

31.6

31.8

0.01

156

1129

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

333

1.90

5.46

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

194

1361

1.43

5.45

3.4

3.0

ratio

1.6

2.0

0.22

133

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.23

5.43

2.6

3.7

mmol/l

0.7

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

139

913

1.53

5.42

2.8

1.6

1.3

0.38

103

719

(3030981) Hyaline casts [#/volume] in Urine by Automated count

400

3146

1.28

5.34

2.9

2.3

e6/l

0.2

0.3

0.64

382

3009

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

442

3523

1.27

5.30

1.6

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

198

1402

1.42

5.29

3.7

3.1

mg/l

34.9

81.7

0.60

156

1130

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

195

1383

1.42

5.18

1.1

125.8

120.6

1.42

176

1253

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

340

1.86

5.15

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

578

1.65

5.13

1.5

1.6

mmol/l

6.1

6.2

0.15

436

(40760888) Immunoglobulin light chains.free panel - Serum

157

1072

1.47

5.11

3.8

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

562

4623

1.23

5.10

1.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

712

5997

1.20

5.09

2.3

2.5

e9/l

4.2

4.0

0.94

581

4980

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

608

5048

1.22

5.05

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

187

1323

1.42

5.04

3.5

u/ml

0.4

0.18

115

735

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

961

8319

1.17

5.02

1.2

iu/ml

163.0

153.6

0.30

406

3314

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

109

691

1.58

5.00

1.8

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

560

1.65

4.97

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1278

11311

1.15

4.97

3.1

3.0

ng/l

409.8

285.2

0.58

746

6685

(3022689) Creatine [Moles/volume] in Urine

173

2.20

4.95

1.6

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

110

701

1.58

4.94

1.4

1.2

u/l

49.8

29.0

0.79

612

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

923

7979

1.17

4.90

6.6

5.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

182

1289

1.42

4.89

3.6

3.7

—

(3018095) Leukocytes [#/volume] in Urine

2714

25182

1.11

4.83

3.8

3.2

e6/l

99.0

82.8

0.54

1945

16418

(3022621) pH of Urine by Test strip

599

4989

1.21

4.83

2.9

2.7

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

524

0.38

4.83

12.7

11.9

nmol/l

653.5

846.2

2.68

504

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

716

6069

1.19

4.79

1.5

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

422

1.74

4.79

1.2

28.3

65.7

—

(3000330) Specific gravity of Urine by Test strip

400

3196

1.26

4.74

3.1

2.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1282

11394

1.15

4.69

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

175

1242

1.42

4.67

2.4

1.9

g/l

129.9

130.2

0.06

142

880

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2953

27565

1.10

4.64

2.0

1.8

pmol/l

99.5

100.4

0.45

1578

13923

(3029396) Erythrocyte agglutination [Presence] in Blood

434

1.71

4.62

3.5

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

295

1.87

4.62

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

963

8394

1.16

4.61

2.3

2.4

umol/l

6.6

6.3

0.17

812

7051

(36304419) Bacteria [Presence] in Urine

1992

18223

1.12

4.57

3.1

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

988

8642

1.16

4.52

4.5

3.8

32.1

33.0

1.79

753

6128

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

194

1417

1.38

4.40

1.4

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

381

1.74

4.38

1.6

1.4

nmol/l

132.0

131.9

0.01

381

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

495

1.64

4.36

1.9

1.7

100.9

101.2

0.03

444

(3045414) Leukocytes [Presence] in Urine

447

3666

1.23

4.23

1.9

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

288

2248

1.29

4.17

1.2

1.3

titre

146.1

148.9

0.02

227

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

715

6138

1.18

4.16

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

1316

1.38

4.09

6.5

5.1

iu/ml

1395.2

703.2

0.54

162

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

505

1.61

4.06

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1959

18016

1.11

4.04

4.3

3.3

—

(4306422)

197

1467

1.35

4.00

1.2

—

(3020650) Glucose [Presence] in Urine

212

1.94

3.90

1.3

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

697

6009

1.17

3.87

2.2

g/l

0.2

0.54

660

5660

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

154

1110

1.39

3.84

2.5

2.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

843

9592

0.87

3.80

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

393

3220

1.23

3.79

6.0

6.1

mmol/l

24.4

24.8

1.36

387

3199

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

483

1.60

3.79

1.6

1.9

u/field

1.9

2.3

0.28

226

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

141

1005

1.41

3.76

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

208

1.93

3.75

2.0

ug/min

25.5

95.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

154

1123

1.38

3.61

1.1

1.3

nmol/l

0.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

675

1.49

3.57

1.2

1.1

—

(3004451) EKG impression Narrative

191

1.94

3.56

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

262

2066

1.28

3.56

1.2

—

(4024509)

103

700

1.48

3.56

1.6

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

555

1.54

3.55

1.6

40.0

38.3

0.14

307

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

3.49

6.7

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

373

3070

1.22

3.48

2.2

2.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

195

1485

1.32

3.45

1.4

mmol/l

6.6

6.9

0.72

153

1091

(3040151) Glucose [Moles/volume] in Capillary blood

607

1.50

3.45

2.1

4.2

mmol/l

8.0

7.5

0.37

490

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

118

831

1.43

3.40

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

199

1525

1.31

3.38

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

555

1.52

3.34

2.6

2.8

60.4

55.7

0.89

358

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

335

2745

1.23

3.28

1.9

2.0

iu/l

30.0

10.0

0.37

128

1124

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

446

1.57

3.28

1.1

1.0

90.3

93.1

0.39

359

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

330

1.67

3.27

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

530

4536

1.18

3.26

1.8

g/l

1.3

0.05

487

4178

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.78

3.25

1.0

1.4

—

(3006315) Basophils [#/volume] in Blood

4105

39325

1.08

3.23

5.9

5.8

e9/l

0.0

0.58

3676

34536

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

140

1029

1.37

3.17

1.1

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

165

1245

1.33

3.15

1.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

144

2.02

3.14

1.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

189

1455

1.31

3.13

1.1

—

(3017704) Immunofixation for Urine

216

1.81

3.08

1.7

1.6

—

(3003338) MCHC [Mass/volume]

6977

71210

0.92

3.07

16.8

13.8

g/l

331.8

331.4

2.89

6934

70737

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

286

2323

1.24

3.07

7.1

4.0

mmol/l

23.8

24.4

2.65

244

2095

(3018418) pH of Serum or Plasma

2162

20230

1.09

3.03

4.7

3.6

7.4

0.32

483

3807

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

214

1683

1.28

3.03

1.3

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3665

35022

1.08

3.02

2.6

2.3

nmol/l

75.2

2603.6

0.50

3401

32454

(3023183) Ammonium ion [Moles/volume] in Plasma

136

1004

1.36

3.02

3.1

2.8

umol/l

34.9

32.7

0.40

120

877

(3005719) IgG [Mass/volume] in Serum or Plasma

670

5880

1.15

3.00

2.8

2.7

g/l

10.5

10.3

0.62

614

5394

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

677

1.44

2.98

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

514

1.50

2.97

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

135

999

1.36

2.96

1.2

1.1

—

(44806420)

2.24

2.95

2.4

2.2

—

(3034614) HLA Ag [Interpretation]

4.71

2.91

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

4.71

2.91

5.5

4.4

mmol/l

0.2

0.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6528

63756

1.08

2.91

3.7

3.5

—

(40768797) Stomach Pathology biopsy report

1199

10931

1.11

2.89

1.2

—

(3001604) Monocytes [#/volume] in Blood

4081

39203

1.07

2.87

5.9

5.7

e9/l

0.5

1.21

3666

34490

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

214

1699

1.27

2.83

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

580

6626

0.87

2.82

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

230

1.74

2.82

1.4

1.1

—

(3047189) Immunofixation for 24 hour Urine

187

1.82

2.77

1.6

1.9

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

410

1.54

2.75

1.1

1.2

u/l

23.6

19.5

0.27

328

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

8.34

2.75

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

152

1.91

2.74

1.7

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

4217

40601

1.07

2.73

5.9

5.7

e9/l

2.0

0.89

3842

36423

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

468

1.50

2.71

1.1

miu/ml

1693.0

1524.0

0.62

468

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

412

1.53

2.70

1.1

1.2

u/l

82.0

78.4

0.13

341

(3023511) Choriogonadotropin [Units/volume] in Urine

402

3423

1.18

2.69

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

477

4121

1.17

2.67

1.3

u/ml

0.5

1.0

1.14

339

(3013115) Eosinophils [#/volume] in Blood

4237

40827

1.07

2.66

6.0

5.9

e9/l

0.2

6.42

3866

36466

(3027456) Digoxin [Moles/volume] in Serum or Plasma

511

1.47

2.65

3.6

3.0

nmol/l

0.8

0.30

385

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

495

0.54

2.63

1.4

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

155

1.87

2.60

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.19

2.56

23.1

7.0

—

(3006598) pH of Arterial cord blood

4.00

2.56

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

188

1491

1.27

2.55

1.4

1.2

u/ml

4.8

3.9

0.35

604

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

362

1.55

2.55

1.1

93.1

95.4

0.30

143

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

155

1986

0.78

2.53

3.8

3.6

u/ml

34.7

31.4

0.13

148

1917

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

435

1.50

2.53

1.6

1.7

nmol/l

2.6

14.9

0.51

360

(3003181) Sodium [Moles/volume] in Urine

120

897

1.34

2.52

1.3

1.4

mmol/l

62.5

63.7

0.13

698

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

129

975

1.33

2.51

1.3

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

238

1944

1.23

2.49

2.5

2.1

g/l

7.4

7.3

0.55

170

1498

(3016650) Hepatitis A virus Ab [Presence] in Serum

167

1311

1.28

2.47

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

133

1014

1.32

2.45

1.1

93.8

94.2

0.05

123

953

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

318

1.58

2.45

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1943

18253

1.08

2.44

1.4

g/l

2.2

2.1

1.66

1236

11445

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1941

1.23

2.43

2.5

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1941

1.23

2.43

2.5

2.1

g/l

3.6

3.7

0.10

157

1418

(37021550) Renin [Units/volume] in Plasma --upright

159

1.83

2.42

1.3

mu/l

37.9

77.0

1.31

123

(3019174) dRVVT (LA screen)

2.09

2.42

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

179

1422

1.26

2.41

1.2

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

5.00

2.40

7.0

3.3

g/l

2.2

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

204

1.72

2.40

2.1

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

192

1540

1.25

2.39

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1925

18096

1.08

2.38

3.7

3.4

101.2

98.1

6.89

1833

17540

(3044009) aPTT.lupus sensitive (LA screen)

2.06

2.36

1.2

—

(21494755) Public health laboratory ask at order entry panel

994

10867

0.90

2.35

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

124

945

1.32

2.31

1.3

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

536

1.42

2.29

1.3

1.4

ug/l

6.6

6.5

0.05

482

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

350

2991

1.18

2.29

1.1

u/ml

7.3

5.4

0.13

473

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

947

1.31

2.28

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

7537

76460

0.93

2.28

13.3

11.8

39.3

39.4

0.85

5608

60987

(3035637) Corticotropin [Mass/volume] in Plasma

128

983

1.31

2.27

1.4

1.5

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.48

2.26

1.6

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

949

1.31

2.25

1.3

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

189

1525

1.24

2.25

1.3

1.2

u/ml

3.6

2.7

0.30

509

(3022670) pH of Venous cord blood

3.89

2.25

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

113

1.95

2.24

5.1

6.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

125

959

1.31

2.23

1.3

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

150

1895

0.79

2.23

1.1

u/ml

2.1

1.6

0.17

453

(3024522) Salmonella sp identified in Specimen by Organism specific culture

124

956

1.30

2.15

1.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

160

1275

1.26

2.14

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

1001

1.29

2.14

1.1

g/l

1.4

1.5

0.68

118

904

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

354

1.50

2.13

1.1

97.1

98.6

0.10

142

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

137

1.83

2.12

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

167

1.74

2.10

1.2

pmol/l

468.5

357.5

0.51

125

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

283

1.56

2.10

1.0

1.1

ng/l

368.6

596.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.00

2.10

2.1

1.8

mmol/l

1.2

0.42

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

421

1.45

2.09

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

583

6515

0.89

2.09

3.2

3.7

ug/l

17.5

23.2

0.22

421

4859

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

364

1.49

2.08

1.5

1.7

u/field

3.0

2.1

0.17

253

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

538

4785

1.13

2.06

1.4

—

(3045716) Anion gap in Serum or Plasma

222

1.62

2.05

4.2

2.7

mmol/l

9.2

0.01

159

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

102

1336

0.76

2.04

1.0

u/ml

0.6

0.3

0.21

269

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

617

1.36

2.04

1.1

mg/l

294.6

305.1

0.66

543

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.00

2.04

5.0

5.4

umol/l

360.0

412.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

686

1.34

2.03

1.3

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

443

0.59

2.03

1.5

—

(3036603) Volume of Urine

466

1.42

2.02

2.0

1.5

2186.9

1958.4

0.57

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

181

1474

1.23

2.02

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

162

1.73

2.01

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

2.01

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

1011

1.28

2.00

1.3

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

140

1.79

2.00

1.4

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

484

1.41

1.99

2.9

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

543

1.38

1.99

1.3

1.5

e6/l

9055.9

58660.7

1.72

378

(3006504) Eosinophils/100 leukocytes in Blood

3809

36814

1.06

1.99

5.9

5.8

2.9

2.8

2.47

3554

34419

(3022806) Fractional oxyhemoglobin in Capillary blood

706

1.33

1.99

1.6

1.7

91.0

90.5

0.44

695

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

435

1.43

1.97

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1862

1.20

1.95

2.6

2.1

g/l

3.0

0.06

164

1465

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

102

778

1.31

1.95

1.7

1.6

52.1

50.7

0.13

463

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

1.0

1.3

—

(3024263) Appearance of Synovial fluid

297

1.52

1.94

2.0

—

(3019069) Monocytes/100 leukocytes in Blood

3826

37004

1.06

1.93

6.2

6.1

7.8

8.0

3.95

3603

34870

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

534

4769

1.13

1.93

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

314

1.50

1.92

1.6

1.4

9.3

4.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2579

24667

1.06

1.90

3.0

3.2

mmol/l

2.3

2.4

2.11

2300

21928

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

459

0.61

1.90

3.5

4.0

—

(3038026) Centromere Ab [Units/volume] in Serum

695

1.33

1.89

1.3

—

55.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

536

4802

1.12

1.85

1.5

1.4

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.21

1.84

1.5

2.9

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

681

1.32

1.83

1.2

1.3

u/ml

52.2

43.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.17

1.82

1.0

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

368

1.44

1.81

1.1

116.8

117.6

0.06

329

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

535

4806

1.12

1.78

1.5

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

124

1552

0.80

1.77

1.0

1.1

u/ml

4.1

4.2

0.03

627

(3014133) Dog dander IgE Ab [Units/volume] in Serum

133

1651

0.80

1.77

1.1

u/ml

3.0

4.7

0.70

613

(3020961) Endomysium IgA Ab [Titer] in Serum

550

4952

1.12

1.76

1.1

titre

104.4

201.8

—

119

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.73

1.3

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.22

1.73

6.2

6.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

213

1797

1.19

1.71

2.1

g/l

10.2

10.1

0.08

178

1534

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

218

1843

1.19

1.71

1.2

mmol/l

3.8

3.6

1.50

202

1733

(21494815) CD4 cells/100 lymphocytes in Specimen

649

0.69

1.70

1.8

2.1

48.6

44.7

—

109

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

517

1.36

1.70

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.95

1.69

26.4

7.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

235

1.53

1.67

2.7

3.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

764

1.29

1.64

1.3

1.4

—

(3008898) HLA-B27 [Presence]

457

4090

1.12

1.64

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

304

2650

1.15

1.63

1.7

1.6

iu/ml

0.1

6.4

0.51

530

(3013650) Neutrophils [#/volume] in Blood by Automated count

4647

45324

1.05

1.62

8.3

8.8

e9/l

4.1

3.9

7.66

4188

39917

(3002030) Lymphocytes/100 leukocytes in Blood

3950

38372

1.05

1.61

6.0

5.8

29.3

29.7

1.73

3685

36036

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.33

1.60

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

523

1.34

1.59

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

575

1.32

1.59

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

106

1.79

1.58

2.7

1.9

mmol/l

1.2

0.46

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

928

9978

0.92

1.58

1.6

1.4

1.3

0.43

821

8962

(3044927) Protein electrophoresis panel - Urine

447

1.37

1.57

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

193

2278

0.84

1.56

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

216

1842

1.18

1.56

1.2

1.3

e6/l

28.6

37.7

0.14

176

1415

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

656

1.30

1.55

1.2

1.3

u/ml

2.4

4.5

—

(3022096) Basophils/100 leukocytes in Blood

3665

35565

1.05

1.55

6.0

5.9

0.7

1.16

3424

33269

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

176

2092

0.84

1.55

3.4

3.3

u/ml

703.0

484.3

0.24

152

1763

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

389

1.39

1.55

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

137

1.68

1.54

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

216

1844

1.18

1.54

1.3

1.4

e6/l

433.8

2902.2

0.66

188

1494

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.97

1.53

1.1

1.0

mmol/l

7.9

8.0

0.11

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

208

1.54

1.53

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

208

1.54

1.53

1.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

108

862

1.26

1.52

1.2

u/l

55.4

57.2

0.14

578

(4268621)

126

1025

1.23

1.50

2.5

2.2

—

(42870588) Differential panel, method unspecified - Blood

2638

25406

1.05

1.50

5.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

495

1.34

1.49

1.6

1.7

113.5

126.5

0.79

463

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

139

1.66

1.47

1.4

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

194

1.55

1.47

1.4

1.6

ug/l

0.4

0.07

135

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

351

1.40

1.46

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1060

0.78

1.46

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

155

1.61

1.46

1.1

1.3

mg/l

0.5

63.7

0.99

114

(3018010) Neutrophils/100 leukocytes in Blood

3894

37892

1.05

1.44

5.8

5.7

56.8

56.3

2.31

3651

35679

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.13

1.44

4.6

3.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.92

1.43

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.73

1.43

1.0

—

(4281824)

1179

0.80

1.43

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

377

3369

1.12

1.43

2.1

u/l

39.3

39.9

0.21

341

3098

(4133840)

180

1.56

1.42

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1232

11620

1.07

1.42

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

572

5230

1.10

1.42

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

195

1665

1.17

1.41

2.4

2.2

g/l

0.5

0.6

0.16

173

1465

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.25

1.40

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

165

1.58

1.39

5.5

6.8

—

(4010399)

485

5332

0.90

1.38

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

280

1.43

1.37

1.5

2.2

ug/l

1.2

0.08

264

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

298

1.41

1.34

2.0

2.4

au/ml

151.0

145.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

265

1.44

1.33

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

265

1.44

1.33

1.2

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

667

7209

0.92

1.32

1.8

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.30

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.09

1.30

1.0

—

(21494434) Karyotype in Bone marrow

394

1.35

1.30

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.89

1.28

1.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

160

1359

1.18

1.27

1.4

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

260

1.42

1.26

20.8

28.4

ug/l

114.1

111.0

0.08

214

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1454

13842

1.06

1.26

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

255

0.59

1.26

1.6

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

311

1.38

1.25

2.1

1.8

mg/l

8.5

9.6

0.82

251

(3043238) Trisomy 21 risk [Likelihood] in Fetus

443

4033

1.10

1.23

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

172

2000

0.86

1.22

1.1

u/ml

2.8

4.8

2.25

1008

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.04

1.21

2.0

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

188

1.49

1.20

1.4

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

1.83

1.19

6.5

4.8

—

(40768441) Liver Pathology biopsy report

603

1.26

1.19

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

247

1.42

1.18

3.2

2.9

umol/l

27.0

27.8

0.19

186

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

189

1.48

1.18

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

238

2097

1.14

1.18

1.3

mg/l

461.2

464.9

0.03

231

1998

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

273

2428

1.13

1.17

1.4

1.5

nmol/l

0.6

0.5

0.24

220

1894

(3024928) Oxygen saturation in Venous blood

123

1030

1.20

1.16

4.9

3.3

—

(3004616) Nuclear Ab [Presence] in Serum

138

1169

1.18

1.15

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

182

1.48

1.15

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

182

1.48

1.15

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

182

1.48

1.15

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

182

1.48

1.15

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

163

1402

1.17

1.14

1.5

1.3

—

(4211845)

430

1.30

1.13

3.3

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

733

1.23

1.13

1.2

1.3

titre

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5712

56232

1.04

1.13

3.1

2.8

u/l

41.7

36.1

5.31

5418

53398

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

541

0.74

1.13

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

183

1.48

1.12

2.0

2.1

—

(3014271) Vancomycin [Susceptibility]

167

1.50

1.12

2.3

3.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

726

1.23

1.11

1.4

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

636

1.24

1.11

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

143

1.54

1.11

1.0

1.1

umol/24h

0.5

0.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

135

1.56

1.11

1.4

ng/l

100.5

78.6

0.70

135

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

223

1967

1.14

1.10

1.3

1.2

u/ml

35.5

9.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

220

0.59

1.10

2.5

1.9

umol/l

17.2

16.5

0.09

220

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

651

0.77

1.09

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.38

1.09

1.2

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

169

1465

1.16

1.08

1.7

e6/l

14073.2

8695.6

0.76

133

1072

(44816559) Phosphatidylethanol [Mass/volume] in Blood

169

1466

1.16

1.07

1.5

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

163

1879

0.87

1.07

1.1

u/ml

2.3

1.0

0.38

757

(3000492) Spirometry study

737

7856

0.93

1.06

1.4

—

(3022145) Colonoscopy Study observation

912

8612

1.07

1.06

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

242

0.62

1.06

2.9

3.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

500

5408

0.92

1.06

1.0

1.1

—

(3048879) Bone marrow aspiration report

121

1.57

1.05

1.2

2.5

—

(4015189)

130

1.54

1.02

2.0

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

871

8227

1.06

1.01

1.3

iu/l

26.9

29.2

1.32

786

7177

(3006270) Folate [Moles/volume] in Blood

599

1.24

1.01

1.2

1.1

nmol/l

384.3

402.4

0.32

555

(3044242) Glucose [Moles/volume] in Arterial blood

213

1.41

1.01

2.1

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

242

2161

1.12

1.01

2.3

2.1

mg/l

10.5

10.4

0.07

225

2017

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

188

1.44

1.01

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

799

1.20

1.01

1.9

mg/l

27.7

25.5

0.14

215

(3052851) Hemolysis interference index of Serum or Plasma

230

2049

1.13

1.00

2.9

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

256

1.37

1.00

2.4

2.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

929

0.82

0.99

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

585

0.77

0.99

2.3

2.7

e9/l

0.2

0.06

491

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

673

1.22

0.99

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

197

2225

0.88

0.98

1.1

u/ml

2.7

1.1

0.72

833

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

318

1.32

0.97

2.5

2.9

mg/l

7.0

7.7

0.41

248

(3002385) Erythrocyte distribution width [Ratio]

7004

69324

1.04

0.97

15.5

13.2

13.6

13.5

0.60

6874

68020

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

292

1.34

0.97

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

152

1321

1.15

0.97

1.4

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

100

840

1.19

0.96

2.2

2.0

u/ml

11.4

1339.2

0.58

757

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

514

0.76

0.96

2.5

2.9

e6/l

844.6

827.4

0.04

233

(3048689) Calprotectin [Mass/mass] in Stool

1275

12203

1.05

0.95

2.5

2.3

ug/g

108.7

103.1

0.29

1022

9503

(3044290) Cell count panel - Cerebral spinal fluid

197

1746

1.13

0.94

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1521

1.14

0.94

2.2

2.1

g/l

0.0

1.70

162

1391

(40765096) Chromosome analysis panel by Banding

133

1.50

0.94

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

116

0.52

0.94

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

338

1.30

0.93

1.2

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

220

2458

0.89

0.93

1.5

1.3

ug/l

3.2

0.04

192

2203

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

330

1.30

0.92

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

589

1.22

0.92

2.8

2.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.67

0.91

2.5

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

384

1.28

0.90

1.2

g/l

0.3

0.14

309

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

131

1134

1.16

0.90

2.8

3.3

u/ml

181.7

610.3

0.97

118

1028

(40768793) Breast Pathology biopsy report

258

2849

0.90

0.89

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

992

0.84

0.89

5.1

5.7

umol/l

366.5

381.1

0.40

854

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

245

1.35

0.88

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

230

0.65

0.88

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

103

1.55

0.87

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.86

0.87

6.0

4.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.86

0.87

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.72

0.86

1.6

2.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.82

0.85

1.0

—

(3005033) Fetal Nuchal fold Thickness US

424

3933

1.08

0.85

1.5

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

163

1440

1.13

0.85

3.9

3.2

mg/l

21.3

23.1

0.32

104

852

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.63

0.84

2.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

188

1.38

0.82

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

570

1.21

0.82

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

354

1.27

0.82

1.0

—

(44813793)

735

1.19

0.82

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

249

1.33

0.81

2.0

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

189

1.38

0.80

1.0

1.1

—

(3025315) Body weight

1.70

0.80

4.8

4.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

737

1.18

0.80

1.4

1.3

umol/l

5.0

5.2

0.17

675

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.0

—

269.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.67

0.78

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

168

1497

1.12

0.78

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

777

1.17

0.77

1.8

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

1.48

0.76

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

111

964

1.15

0.76

1.1

—

25.8

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.77

0.76

1.0

—

4.2

—

(3021788) Differential panel - Synovial fluid

130

1142

1.14

0.76

1.5

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

187

2077

0.90

0.76

1.3

1.2

—

(3000012) Reticulocyte production index

288

1.29

0.75

1.5

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

197

0.66

0.75

1.6

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

422

3943

1.07

0.73

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

654

1.18

0.71

2.2

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

515

5463

0.94

0.71

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

282

3057

0.92

0.70

1.5

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

177

1.36

0.70

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

598

0.82

0.70

1.7

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.71

0.70

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1136

10938

1.04

0.69

2.7

2.4

e6/l

1.3

1.2

0.16

701

5883

(3006462) Nitrate [Presence] in Urine

391

1.23

0.68

2.8

3.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

583

1.18

0.68

1.0

1.1

u/l

1.0

1.1

1.20

232

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

106

927

1.15

0.68

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

226

2067

1.10

0.68

1.3

u/ml

0.9

3.0

2.03

156

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

222

1.31

0.67

1.7

1.8

—

(3011648) Oxygen content in Venous blood

410

1.22

0.67

3.4

2.2

11.3

10.9

0.38

410

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

185

1676

1.11

0.67

2.0

2.1

ug/l

214.2

481.0

1.15

170

1500

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

680

7139

0.95

0.67

3.1

u/ml

40.7

40.2

0.02

657

6893

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1607

15602

1.04

0.65

2.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.54

0.65

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

277

1.26

0.65

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

395

1.22

0.64

1.3

1.4

u/ml

22.3

19.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

269

1.26

0.63

1.4

—

(3016038) Potassium [Moles/volume] in Urine

351

1.23

0.62

1.2

mmol/l

28.3

34.2

1.33

302

(36660697) Celiac disease serology panel - Serum

816

7825

1.05

0.62

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2554

25011

1.03

0.61

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

147

1.36

0.61

1.5

1.3

42.6

43.2

0.02

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.60

0.61

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

601

6305

0.95

0.60

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.50

0.59

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.50

0.59

2.2

2.1

u/field

0.9

0.05

(3014051) Protein [Presence] in Urine by Test strip

197

1806

1.09

0.59

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.53

0.59

1.9

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.58

0.0

1.0

—

(44806071)

140

1.36

0.58

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

105

932

1.13

0.57

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

365

0.79

0.57

2.2

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

1.42

0.57

1.8

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

328

1.22

0.57

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.43

0.56

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.43

0.56

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

485

1.18

0.55

3.0

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

493

4685

1.06

0.55

1.5

1.6

mu/l

270.8

315.5

3.38

430

4165

(3000093) Morphology [Interpretation] in Blood Narrative

513

1.17

0.55

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

108

964

1.12

0.55

1.1

—

75.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.46

0.54

1.4

15.9

20.9

0.49

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

711

1.14

0.54

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

166

1519

1.09

0.53

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

162

1481

1.10

0.53

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

118

1063

1.11

0.52

3.5

4.5

u/ml

115.0

99.3

0.11

339

(3015183) Erythrocyte sedimentation rate

563

1.16

0.52

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

276

2583

1.07

0.52

1.3

u/ml

14.5

6.5

0.46

280

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

179

1647

1.09

0.52

1.1

u/ml

3.6

2.8

0.22

884

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

315

0.79

0.51

1.4

1.5

u/l

11.6

11.4

0.06

302

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.50

0.51

1.2

1.3

u/l

24.5

715.8

—

(3045788) Cell count panel - Pleural fluid

314

0.80

0.50

1.9

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

596

0.85

0.50

2.2

2.6

e6/l

562.8

509.6

0.36

489

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

288

1.22

0.50

1.2

1.1

u/ml

45.8

54.4

0.36

280

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

501

1.16

0.49

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

501

1.16

0.49

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

501

1.16

0.49

1.3

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

280

2629

1.07

0.49

1.3

u/ml

11.9

7.6

0.35

443

(4094501)

188

1743

1.08

0.47

1.1

—

(3001729) Color of Synovial fluid

1.46

0.46

1.1

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

872

1.11

0.46

1.5

1.4

g/l

6.5

6.7

0.16

605

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

383

1.18

0.46

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

216

2313

0.93

0.46

1.2

1.3

u/ml

46.8

43.4

0.11

249

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

337

1.19

0.46

1.5

1.4

pmol/l

14.0

0.00

281

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.45

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

120

0.67

0.45

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

241

2568

0.94

0.45

1.2

—

(3028433) Virus identified in Specimen by Culture

237

1.22

0.45

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

103

1.36

0.45

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

374

0.83

0.45

2.8

45.6

44.8

0.06

147

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

1.28

0.45

1.2

—

(3023410) Appearance of Cerebral spinal fluid

906

0.89

0.44

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

357

1.18

0.44

1.2

1.3

—

603.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

265

1.21

0.44

1.1

1.2

—

(40768443) Skin Pathology biopsy report

324

3418

0.95

0.44

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

895

1.11

0.44

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

957

0.90

0.43

1.5

1.4

—

2890.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

507

1.14

0.43

1.1

u/ml

12.6

9.2

0.18

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

220

1.23

0.43

1.1

103.6

87.4

—

(3025130) Human papilloma virus identified in Specimen

224

2388

0.94

0.43

1.6

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

673

6973

0.96

0.43

2.7

2.3

u/l

41.9

35.8

0.38

558

5939

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

517

1.14

0.43

1.5

1.6

u/l

12.6

4.6

1.46

251

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1062

10332

1.03

0.43

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

241

2562

0.94

0.43

1.2

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

660

6368

1.04

0.42

1.3

u/ml

164.9

181.3

0.20

614

5890

(3049717) Cytology report of Urine Cyto stain

145

1338

1.09

0.42

2.0

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

279

2638

1.06

0.42

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.52

0.41

1.8

7.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

231

1.21

0.41

1.6

1.7

ug/l

9.7

8.5

0.70

231

(1002224) Polysomnography panel

388

3705

1.05

0.41

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

161

0.75

0.41

1.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

213

1.22

0.40

3.5

4.4

—

(4027681)

662

1.12

0.40

1.4

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

122

1121

1.09

0.40

1.3

nmol/l

1.2

1.4

0.99

101

917

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.40

1.3

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

872

1.10

0.40

1.5

1.4

g/l

3.1

2.9

0.52

602

(3000494) Fungus identified in Specimen by Culture

868

8936

0.97

0.40

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

5.6

—

4.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

873

1.10

0.39

1.5

1.4

g/l

0.4

0.47

606

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.43

0.39

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.43

0.39

1.2

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

290

2753

1.06

0.39

1.2

u/l

12.2

13.3

0.71

242

2280

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.39

0.38

1.2

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.39

0.38

6.0

3.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.35

0.37

1.1

—

(3023419) Bacteria identified in Sputum by Culture

674

0.89

0.37

2.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

723

1.11

0.37

1.4

1.2

u/ml

0.6

1.0

0.50

287

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

324

3089

1.05

0.37

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

652

0.89

0.37

1.0

u/ml

0.1

0.3

—

(3024869) Neuronal Ab [Presence] in Serum

113

0.71

0.37

1.3

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

113

0.71

0.37

1.3

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

0.69

0.36

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

649

1.11

0.36

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

168

0.77

0.35

1.8

1.5

u/l

10.9

48.8

1.64

147

(3014891) Appearance of Pleural fluid

1.43

0.35

1.3

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

391

4073

0.96

0.35

1.9

—

(4062490)

870

1.09

0.35

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

298

3124

0.95

0.35

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

394

4102

0.96

0.35

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

199

1.21

0.35

1.1

—

(3027008) Opiates [Presence] in Urine

393

4091

0.96

0.34

1.8

1.9

—

(3034426) Prothrombin time (PT)

320

1.16

0.34

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

227

1.19

0.34

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

303

2895

1.05

0.34

1.3

u/ml

23.6

36.0

0.39

207

(3033799) Differential panel - Peritoneal fluid

154

1.23

0.33

1.5

2.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

349

1.15

0.33

1.2

1.3

titre

64.0

49.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

270

2573

1.05

0.33

8.6

8.8

mmol/l

23.9

24.3

1.29

245

2437

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.68

0.33

1.3

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.67

0.32

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

242

0.83

0.32

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

241

2532

0.95

0.32

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

104

962

1.08

0.32

1.4

nmol/l

25.8

31.4

1.64

883

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

445

1.12

0.32

1.9

2.0

ug/l

66.6

21.8

0.45

437

(3008757) Leukocyte morphology finding [Identifier] in Blood

626

1.10

0.32

2.9

3.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

313

1.15

0.32

1.1

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.30

0.31

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

162

1525

1.06

0.31

1.8

2.0

g/l

38.1

38.7

0.54

143

1340

(3016879) Cocaine [Presence] in Urine

359

3733

0.96

0.31

1.9

2.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.35

0.31

1.0

1.1

—

31.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.35

0.31

1.0

1.1

—

15.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

622

6401

0.97

0.31

2.3

au/ml

17.2

23.6

0.84

479

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

791

1.09

0.30

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.32

0.30

1.3

1.1

u/l

11.7

12.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1201

12248

0.98

0.30

2.4

2.6

mmol/l

2.4

0.02

1054

10702

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

451

4665

0.97

0.30

1.8

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

373

3593

1.04

0.30

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

495

1.11

0.30

1.1

nmol/l

0.2

7.2

1.07

(3030313) Adrenal Ab [Titer] in Serum

120

1.25

0.30

1.1

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

572

5888

0.97

0.29

1.3

au/ml

45.0

42.0

0.09

232

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

325

1.14

0.29

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

325

1.14

0.29

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

325

1.14

0.29

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

325

1.14

0.29

1.3

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

736

1.09

0.29

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

106

0.75

0.29

1.0

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

110

0.73

0.28

1.1

2.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

143

1347

1.06

0.28

1.5

g/l

0.5

0.6

0.78

111

1007

(3042517) Benzodiazepines panel - Urine

129

0.77

0.28

1.8

2.2

—

(3016018) Differential panel - Cerebral spinal fluid

922

1.07

0.27

1.3

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

537

1.10

0.27

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

120

0.75

0.27

1.6

—

(3000285) Sodium [Moles/volume] in Blood

1.23

0.27

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

531

0.90

0.26

1.2

—

(3011412) CD3 cells [#/volume] in Blood

791

0.92

0.26

2.1

2.5

e9/l

1.4

1.3

0.28

467

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

164

1557

1.05

0.26

2.6

—

(3051651) Icteric interference index of Serum or Plasma

394

0.89

0.26

3.6

3.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

160

1.19

0.25

1.1

u/ml

0.0

—

103

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

387

1.11

0.25

1.6

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

725

1.08

0.24

1.1

u/ml

0.3

1.6

1.36

184

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

658

1.08

0.23

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

284

1.13

0.23

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

4369

1.03

0.23

1.4

1.3

miu/ml

191.7

235.1

2.19

206

2219

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

338

0.89

0.23

1.1

1.0

ng/l

45.5

43.2

0.12

245

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

231

2222

1.04

0.23

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

558

5449

1.03

0.22

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.25

0.22

1.2

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

170

1777

0.96

0.22

2.4

2.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.22

0.22

1.2

1.9

0.3

0.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.22

0.22

1.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

241

2498

0.96

0.21

1.3

1.4

u/l

24.3

29.1

1.62

199

2035

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

336

0.89

0.21

1.1

1.0

ng/l

619.3

762.4

1.14

245

(40765089) Chromosome analysis panel - Blood by G-banded

294

0.88

0.21

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

12097.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

(40758558) Short blood count panel - Blood

1951

19721

0.99

0.21

5.9

6.6

—

(3012441) Differential panel - Pleural fluid

325

0.89

0.21

2.1

1.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

2639.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.5

—

(40763791) Oxygen content in Venous blood by calculation

0.00

0.21

0.0

6.6

—

10.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

364

3540

1.03

0.20

2.4

2.3

—

(3045142) Bone marrow Pathology biopsy report

576

1.08

0.20

1.6

1.3

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

2.4

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

209.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

164

1.16

0.20

1.2

g/l

35.8

38.3

0.24

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.22

0.20

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

112

0.80

0.20

1.1

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

146

1397

1.05

0.19

1.9

2.1

g/l

0.0

0.50

136

1272

(3032057) Clostridioides difficile [Presence] in Stool

127

1.18

0.19

2.2

1.8

—

(40768795) Lymph node Pathology biopsy report

772

1.06

0.19

1.2

—

(3007463) Buprenorphine [Presence] in Urine

1.18

0.19

2.5

4.8

—

(3002619) Bacteria identified in Specimen by Culture

146

1.16

0.19

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.22

0.19

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

270

0.89

0.19

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

401

3913

1.03

0.19

1.1

u/ml

1.2

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

735

1.06

0.18

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

132

0.83

0.18

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

100

1.20

0.18

1.3

1.2

mmol/l

2.8

3.5

0.67

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

300

0.90

0.18

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

217

2100

1.03

0.18

1.4

ug/g

304.7

299.2

0.13

125

1109

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

712

0.94

0.17

1.1

iu/ml

3.6

7.7

3.07

202

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.75

0.17

1.4

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

514

1.07

0.16

1.4

1.5

u/l

5.7

5.2

0.45

438

(3027944) Amphetamines [Presence] in Urine

395

4039

0.98

0.16

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.18

0.16

1.0

1.1

umol/24h

1.6

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

101

1.19

0.16

1.2

1.7

ng/l

95.0

64.6

—

(4035726)

645

6559

0.98

0.16

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

690

0.94

0.16

2.1

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

638

0.94

0.16

1.9

2.1

13.5

13.0

0.12

331

(4198724)

399

1.08

0.15

1.8

2.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

172

0.87

0.15

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

172

0.87

0.15

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

172

0.87

0.15

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

349

0.92

0.15

2.0

2.3

umol/l

291.3

146.1

0.54

186

(3016330) Potassium [Moles/time] in 24 hour Urine

130

1.15

0.15

1.2

—

89.6

—

(40768804) Tissue Pathology biopsy report

3557

35761

0.99

0.15

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

255

0.90

0.15

1.5

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.18

0.14

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

150

1.13

0.14

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

645

1.05

0.14

5.1

6.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

655

1.05

0.14

1.3

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

812

1.05

0.14

1.2

1.1

mg/l

204.3

215.3

0.47

711

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

803

1.05

0.13

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

803

1.05

0.13

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

623

0.95

0.13

1.2

titre

250.0

168.2

—

115

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

253

0.91

0.13

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

253

0.91

0.13

1.5

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

383

1.07

0.13

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

167

1720

0.97

0.13

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.17

0.13

1.8

2.0

umol/l

1.3

0.41

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

335

0.93

0.13

1.1

1.0

ng/l

1608.6

350.4

0.50

249

(3025018) Bordetella pertussis Ab [Titer] in Serum

638

1.05

0.12

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

252

0.91

0.12

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

805

1.04

0.12

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.18

0.12

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

796

1.04

0.12

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

590

1.05

0.12

1.5

1.6

—

(3044941) Cell count panel - Synovial fluid

936

0.96

0.12

1.3

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

797

1.04

0.11

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

209

0.91

0.11

1.1

—

(3044007) Cell count panel - Peritoneal fluid

153

1.11

0.11

1.8

2.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

455

0.94

0.11

1.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

230

2252

1.02

0.11

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

799

1.04

0.11

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

573

1.05

0.10

1.3

g/l

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

348

1.06

0.10

1.6

umol/l

30.8

30.3

0.11

339

(3003740) Influenza virus B Ag [Presence] in Specimen

171

1752

0.98

0.10

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

270

1.07

0.10

3.4

1.7

—

(44790049)

672

1.04

0.10

1.4

1.5

—

(44790047)

672

1.04

0.10

1.4

1.5

—

(44790048)

672

1.04

0.10

1.4

1.5

—

(44806118)

672

1.04

0.10

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

806

7981

1.01

0.10

1.7

—

(3010503) CD19 cells [#/volume] in Blood

453

0.95

0.10

2.1

2.7

e9/l

0.1

0.3

1.65

443

(3019977) pH of Arterial blood

271

1.07

0.09

1.7

3.0

7.4

1.14

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

1.10

0.09

1.1

1.0

—

(40758358) Immune stain study

1.04

0.09

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

523

0.96

0.09

1.3

1.4

—

(3002256) Pathology report gross observation

1071

10788

0.99

0.08

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

298

2935

1.02

0.08

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

0.91

0.08

1.8

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

0.91

0.08

1.8

3.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

410

0.95

0.08

1.5

1.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

834

1.03

0.08

1.3

1.1

mg/l

34.9

37.2

0.23

698

(3005011) Chlamydia sp Ab [Titer] in Serum

144

0.90

0.08

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

172

1754

0.98

0.08

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

287

0.94

0.08

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

141

1380

1.02

0.08

2.0

2.1

g/l

0.0

0.00

134

1269

(40762365) Oxygen content in Arterial blood by calculation

0.84

0.07

1.3

1.9

ml/dl

14.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.84

0.07

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.81

0.07

1.0

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

176

1.08

0.07

1.3

nmol/l

94.6

108.0

0.36

130

(3022475) Manganese [Moles/volume] in Blood

1.05

0.07

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.03

0.07

1.0

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

367

0.95

0.07

1.6

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

204

0.93

0.07

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

1007

1.02

0.06

1.8

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

669

0.97

0.06

3.2

2.9

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

709

0.97

0.06

1.0

u/ml

0.6

0.9

0.43

151

(40757373) Influenza virus identified in Isolate

121

0.91

0.06

1.7

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

692

1.03

0.05

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

267

1.05

0.05

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

159

1.07

0.05

1.5

2.1

e6/l

3324.7

21140.2

—

(3017509) Phencyclidine [Presence] in Urine

120

0.92

0.05

1.1

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

248

1.05

0.05

3.8

2.7

ng/l

77.8

94.4

0.22

(3003327) Ova and parasites identified in Stool by Light microscopy

342

3449

0.99

0.04

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

288

1.04

0.04

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

180

0.94

0.04

1.4

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

111

1.08

0.04

1.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

279

1.04

0.04

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

696

1.02

0.04

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

402

4045

0.99

0.03

1.8

1.6

mg/l

3.8

3.2

1.22

302

2774

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

131

1.07

0.03

1.0

u/ml

0.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

220

0.95

0.03

1.3

2.1

ug/l

1.5

3.6

1.02

129

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1018

10146

1.00

0.03

2.8

2.5

e6/l

5.9

4.7

1.65

581

5118

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

1.03

0.03

1.7

1.4

e6/l

67137.5

41544.0

0.30

193

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

159

0.94

0.03

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

342

3399

1.01

0.03

2.2

2.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

602

0.98

0.03

1.9

2.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

130

1315

0.99

0.03

1.3

u/ml

14.8

61.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

166

1644

1.01

0.03

1.1

au/ml

7.4

10.7

—

115

(3023420) DNA double strand Ab [Units/volume] in Serum

107

1083

0.99

0.02

2.0

1.6

iu/ml

29.6

32.4

0.15

(1175426) CD3 cells/100 lymphocytes in Blood

650

0.98

0.02

1.9

2.1

77.3

75.1

0.85

628

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.08

0.02

3.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

737

7385

1.00

0.01

1.5

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

327

0.98

0.01

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

1252

1.01

0.01

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

1252

1.01

0.01

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

737

0.99

0.01

1.2

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.06

0.01

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

106

0.94

0.01

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

394

1.02

0.00

1.7

1.4

e6/l

1551.6

2673.6

1.12

284

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

157

1.02

0.00

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

233

0.99

0.00

2.0

1.1

—

(3035880) pH of Pleural fluid

184

0.98

0.00

1.6

1.2

—

(3008295) Osmolality of Serum or Plasma

626

1.01

0.00

1.3

1.6

mosm/kgh2o

280.8

278.8

0.31

498

(3004446) Plasmodium sp identified in Blood by Light microscopy

105

0.95

0.00

1.4

2.6

—

(3001556) Androgen free Index in Serum or Plasma

115

0.96

0.00

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

325

0.98

0.00

1.1

u/ml

0.2

2.1

1.77

174

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

585

0.99

0.00

1.4

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

712

1.00

0.00

1.0

—

(3011288) Drugs identified in Urine by Screen method

282

2819

1.00

0.00

2.6

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

269

1.00

0.00

1.8

2.2

e6/l

128.2

186.3

0.53

142

(21494814) CD8 cells/100 lymphocytes in Specimen

301

1.00

0.00

1.7

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

289

1.00

0.00

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

499

1.00

0.00

1.7

1.5

promille

0.8

1.3

1.37

380

(3023487) Leukocytes [#/volume] in Peritoneal fluid

179

1.01

0.00

1.7

2.3

e6/l

351.3

945.9

1.42

115

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

151

0.99

0.00

1.1

nmol/l

0.4

—

(3050794) Legionella sp Ab [Presence] in Serum

0.88

0.00

1.0

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

29.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.02

0.00

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

539

5390

1.00

0.00

1.5

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.00

0.00

2.7

1.3

18.9

25.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.94

0.00

1.0

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.91

0.00

6.7

6.0

umol/l

0.4

0.3

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

310.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

5.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

3.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.3

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.2

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_PREECLAMPS and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_PREECLAMPS	0.737 [0.61, 0.89]	0.001
Birth year	0.994 [0.99, 1.0]	0.148

During the follow-up period (1.1.1998 — 31.12.2019), 168 out of 27833 females with O15_PREECLAMPS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_PREECLAMPS.

N-year risk	Females	Males
1	0.083%	No data
5	0.476%	No data
10	1.128%	No data
15	2.111%	No data
20	3.704%	No data

Relationships between endpoints

↥

Index endpoint: O15_PREECLAMPS – Pre-eclampsia

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-eclampsia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints